| OA15.03 | Novel trimer-only (TO) producing HIV-1 envelope glycoprotein constructs for inducing broadly neutralizing antibody responses by genetic vaccination | Oral Abstract Session | Novel vaccine and other prevention approaches |
| OA15.02 | In vitro and in vivo analyses of HIV-1 clade C Envelope trimers highlight optimal antigenic profiles of novel HIV-1 Env-based vaccine candidates | Oral Abstract Session | Novel vaccine and other prevention approaches |
| OA15.01 | Heterologous vaccination with DNA and two different poxvirus vectors, expressing HIV-1 envelope on the surface of Gag virus-like particles, elicit autologous Tier 2 neutralising antibodies | Oral Abstract Session | Novel vaccine and other prevention approaches |
| OA14.05LB | Impact of HIV kick-and-kill therapy on host epigenetic and transcriptional programs in PBMC, and viral rebound after cART interruption | Oral Abstract Session | Cellular immunity |
| OA14.04 | Targeting Sphingosine-1-phosphate signaling prevents cell-to-cell transmission of HIV-1 | Oral Abstract Session | Therapeutic vaccines, viral reservoirs and eradication/remission |
| OA14.03 | Analysis of the early responses to HIV-1 in matched treatment naïve individuals reveals early soluble proteins that are associated with in vivo virus control | Oral Abstract Session | Innate and trained immunity |
| OA14.02 | Unprimed CD8+ lymphocytes promote the maintenance of HIV latency in CD4+ T cells | Oral Abstract Session | Therapeutic vaccines, viral reservoirs and eradication/remission |
| OA14.01 | Improved killing of HIV-infected cells by a combination of three neutralizing and non-neutralizing antibodies | Oral Abstract Session | Therapeutic vaccines, viral reservoirs and eradication/remission |
| OA13.05LB | Utilizing a robust HIV prevention community engagement framework to engage communities in COVID-19 prevention efforts | Oral Abstract Session | Community engagement in prevention research |
| OA13.04 | The COVID-19 pandemic and transition to telehealth: appointment attendance and patient perspectives at an adult HIV clinic | Oral Abstract Session | Behavioural and social science research |